Cardiovascular Risk Reduction

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have prov…

Expiration Date: 7/15/2020

Max Credits: 0.75

View Activity

Test Your Knowledge in the Use of PCSK9 Inhibitors in the Reduction of CV Risk: A Wheel of Knowledge Challenge

Test Your Knowledge in the Use of PCSK9 Inhibitors in the Reduction of CV Risk: A Wheel of Knowledge Challenge

As clinical data emerge regarding the benefit of proprotein convertase sub…

Expiration Date: 1/9/2020

Max Credits: 1.5

View Activity

Advancing Science in Residual Cardiovascular Risk: Will New Cardiovascular Outcomes Trials Bring a Paradigm Shift in Patient Care?

Advancing Science in Residual Cardiovascular Risk: Will New Cardiovascular Outcomes Trials Bring a Paradigm Shift in Patient Care?

Despite therapeutic advances, cardiovascular disease (CVD) continues to be…

Expiration Date: 1/3/2020

Max Credits: 1.25

View Activity

PCSK9 Inhibitors in Prevention: How to Use Them Like the Experts

PCSK9 Inhibitors in Prevention: How to Use Them Like the Experts

As clinical data emerge regarding the benefit of proprotein convertase sub…

Expiration Date: 8/30/2019

Max Credits: 0

View Activity

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Nearly one-third of adults in the United States have an elevated low-densi…

Expiration Date: 3/8/2019

Max Credits: 0

View Activity

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

With each passing year we gain new insight and understanding around the cl…

Expiration Date: 8/11/2018

Max Credits: 0

View Activity

Patient Identification

Patient Identification

Dr. Bonaca evaluates the mechanisms, benefits, and risks of current antipl…

Expiration Date: 2/23/2017

Max Credits: 0

View Activity

Anti-platelet Therapy

Anti-platelet Therapy

Dr. Mahaffey reviews the historical use of antiplatelet therapy in patient…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

High-risk Patient

High-risk Patient

Dr. Steg examines the burden and independent predictors of cardiovascular …

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Hypertriglyceridemia: Current Approaches to Management

Hypertriglyceridemia: Current Approaches to Management

Dr. Toth discusses incorporating various pharmacotherapies for the treatme…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity